ACT-NOW Implementation Guide
0.4.0 - ci-build
ACT-NOW Implementation Guide
0.4.0 - ci-build
ACT-NOW Implementation Guide, published by Te aho o te kahu - Cancer Control Agency. This guide is not an authorized publication; it is the continuous build for version 0.4.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/davidhay25/actnow/ and changes regularly. See the Directory of published versions
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
The following artifacts define the specific capabilities that different types of systems are expected to have in order to comply with this implementation guide. Systems conforming to this implementation guide are expected to declare conformance to one or more of the following capability statements.
| CapabilityStatement representing the server requirements for a FHIR server |
Server capability statement |
These define constraints on FHIR resources for systems conforming to this implementation guide.
| ACT-NOW diagnosis |
The primary diagnosis for this cancer. Can have an evidence.detail reference to an Observation that has the histology and a stage.assessment reference to the TNM Observation staging (clinical and pathological) |
| ACT-NOW medication administration |
ACT-NOW medication administration. These are medications that were actually administered. |
| ACT-NOW medication request |
ACT-NOW medication request. These are prescriptions given to the patient. |
| ACT-NOW patient |
ACT-NOW patient |
| Body Surface Area |
An observation that represents a Body Surface Area measurement |
| Clinical M-score |
An observation that represents the clinical 'M' score |
| Clinical N-score |
An observation that represents the clinical 'N' score which measures local lymph node involvement. |
| Clinical T-score |
An observation that represents the clinical 'T' score which measures the tumour size. |
| Clinical TNM group score |
An observation that represents the clinical TNM group score |
| Creatinine Clearance |
An observation that represents a Creatinine Clearance measurement |
| Cycle Careplan |
A CarePlan that represents a single cycle of treatment. It will have a 'partOf' reference to the regiment carePlan. |
| ECOG score |
An observation that represents an ecog score |
| Estrogen Receptor status |
An observation that represents an ER status |
| Gleason score |
An observation that represents the Gleason score |
| HER2 status |
An observation that represents a HER2 status |
| Height |
An observation that represents a height measurement |
| Histology |
An observation that represents a Histology finding |
| PR status |
An observation that represents a Progesterone Receptor status |
| Pathological M-score |
An observation that represents the pathological 'M' score which measures distant metastases. |
| Pathological N-score |
An observation that represents the pathological 'N' score which measures local lymph node involvement. |
| Pathological T-score |
An observation that represents the pathological 'T' score which measures tumour size. |
| Pathological TNM group score |
An observation that represents the pathological TNM group score |
| Regimen Careplan |
A CarePlan that represents a PlanDefinition being applied to a Patient. Referred to as a regimen. The regimen has multiple cycles also represented as CarePlans which have a 'partOf' reference back to the regimen plan. |
| Weight |
An observation that represents a weight measurement |
These define constraints on FHIR data types for systems conforming to this implementation guide.
| ClinicalTrial |
Is on a clinical trial |
| CourseNumber |
The course number (sequential number) for this regimen |
| CycleCount |
The number of cycles that administered for a regimen |
| CycleDay |
The day of the cycle that this medication was given on. Includes planned day and administered day. Not the same as intended cycle length. |
| CycleNumber |
The cycle number of the regimen that this CP represents |
| CyclePlannedLength |
The number of cycles that administered for a regimen |
| DependsOn |
Indicates the type of comparison performed when ecaluating the target 'depends-on' value if it is not simple equality |
| DoseAdjustmentReason |
The reason why the dose given was not the same as that in the regimen |
| FacilityAdministered |
The facility where the medication was given. The HPI code of the facility |
| IOT |
Intent of treatment |
| LastAdminDate |
The last date that a medication administration was made for this cycle |
| PrescribedDose |
The dose of this medication in the regimen (may not be the same as that given |
| RecurrenceType |
Recurrence type |
| Regimen type |
The overall type of the regimen - eg FOLFOX |
| RegimenDiscontinued |
Reasons why a regimen may have been discontinued |
| RegimenOTU |
Overall Treatment Utility measure for a regimen after it has completed. |
These define sets of codes used by systems conforming to this implementation guide.
| Basis of diagnosis |
Whether the diagnosis is based on clinical or pathological grounds |
| Dose adjustment reason |
What was reason the dose was adjusted |
| ECOG status |
ECOG status |
| ER status |
Estrogen Receptor status |
| ER status |
Estrogen Receptor status |
| HER2 status |
Human epidermal growth status |
| Intent of treatment |
What was the purpose of this treatment |
| Outcome of a regimen |
How did applying the regimen affect the patient |
| Patient factors when discontinuing a regimen |
Patient factors when discontinuing a regimen |
| The reason why a regimen was discontinued |
The reason why a regimen was discontinued |
| Toxicity reasons why a regimen was discontinued |
Toxicity reasons why a regimen was discontinued |
| Type of recurrence |
Type of recurrence |
These define new code systems used by systems conforming to this implementation guide.
| Outcome of a regimen |
How did applying the regimen affect the patient |
| The reason why a regimen was discontinued |
The reason why a regimen was discontinued |
These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.
| Clincial M value | |
| Clincial N value | |
| Clinical T value | |
| Clinical TNM group | |
| CreatinineClearance | |
| Cycle 1 |
Example of a cycle care plan |
| ERStatus | |
| ExObservationECOG | |
| ExObservationGleason | |
| ExObservationHeight | |
| ExObservationNoValueSystemWeight | |
| ExObservationWeight | |
| Example practitioner | |
| HER2Status | |
| Histology: Small cell lung cancer | |
| Lorrie Lung | |
| PRStatus | |
| Pathological M value | |
| Pathological N value | |
| Pathological T value | |
| Pathological TNM group | |
| Small cell lung cancer diagnosis | |
| bsa | |
| careplan-regimen-1 |
Example of a regimen care plan |
| careplan-regimen-2 |
A regimen care plan that was discontinued after it started |
| cp-supporting-info |
Searches for supportingInfo references |
| medicationadministration-1 |
An example medication administration |
| medicationrequest-1 |
An example medication administration |